The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
A once-a-week injection that can offer ‘complete viral-load suppression’ for up to 17 months, could be available from 2017 according to Pharmaceutical company CytoDyn Inc. following a trial of 23 patients.
AVERT has launched a new partnership to support communities affected by the dual epidemics of HIV and tuberculosis (TB) in Zambia, thanks to funding from Comic Relief.
Family planning is not only about the rights of women and girls to make their own choices about having children and looking after their reproductive health, it's also key to global development.
Number of people living with HIV in Russia reaches 1 million. People aged 25-35 are particularly effected, with injecting drug use and heterosexual sex the most common routes of transmission.
Lack of information and access to contraceptives is leading to many girls in Uganda having unwanted pregnancies. Angela Tweheyo, 17, from Mbarara District, is one of them.
The recent approval of the drug Truvada in Kenya as PrEP reflects commitment from the regulatory authority to fast-track the review of drugs of public health importance.